Latest Articles

  • Combined hormonal contraceptives and migraine: An update on the evidence
    Anne H. Calhoun, MD, FAHS and Pelin Batur, MD, FACP, NCMP
    Cleveland Clinic Journal of Medicine August 2017, 84 (8) 631-638; DOI: https://doi.org/10.3949/ccjm.84a.16033

    These contraceptives are contraindicated in women who have migraine with aura, but benefit vs risk is debatable.

  • In reply: Opioid therapy and sleep apnea (June 2016)
    Marissa C. Galicia-Castillo, MD
    Cleveland Clinic Journal of Medicine February 2017, 84 (2) 94; DOI: https://doi.org/10.3949/ccjm.84c.02002
  • Delirium in hospitalized patients: Risks and benefits of antipsychotics
    Robyn Pauline Thom, MD, Clare Kelleher Mock, MD and Polina Teslyar, MD
    Cleveland Clinic Journal of Medicine August 2017, 84 (8) 616-622; DOI: https://doi.org/10.3949/ccjm.84a.16077

    No drug is approved for delirium, but antipsychotics can be used in certain situations.

  • Opioid therapy and sleep apnea (June 2016)
    Aaron S. Geller, MD
    Cleveland Clinic Journal of Medicine February 2017, 84 (2) 91-94; DOI: https://doi.org/10.3949/ccjm.84c.02001

    Readers comment on opioids and sleep apnea (June 2016).

  • Reproductive planning for women after solid-organ transplant
    Mina Al-Badri, MBCHB, Juliana M. Kling, MD, MPH and Suneela Vegunta, MD
    Cleveland Clinic Journal of Medicine September 2017, 84 (9) 719-728; DOI: https://doi.org/10.3949/ccjm.84a.16116

    Pregnancy can succeed, but patients must wait at least a year. Until then, meticulous contraception is mandatory.

  • Serotonin syndrome (November 2016)
    Cielo Z. Rose, DO
    Cleveland Clinic Journal of Medicine May 2017, 84 (5) 342-343; DOI: https://doi.org/10.3949/ccjm.84c.05001

    A reader comments on serotonin syndrome (November 2016).

  • Antibiotic stewardship: Why we must, how we can
    Arjun Srinivasan, MD, FSHEA, CAPT USPHS
    Cleveland Clinic Journal of Medicine September 2017, 84 (9) 673-679; DOI: https://doi.org/10.3949/ccjm.84gr.17003

    It has always been a good idea; now it is required.

  • A rational approach to opioid use disorder in primary care
    Daniel G. Tobin, MD, FACP
    Cleveland Clinic Journal of Medicine May 2017, 84 (5) 385-387; DOI: https://doi.org/10.3949/ccjm.84a.17030

    Treating addiction is quickly becoming part of primary care. Clinicians can no longer turn a blind eye toward this problem.

  • Use and misuse of opioid agonists in opioid addiction
    Use and misuse of opioid agonists in opioid addiction
    Vania Modesto-Lowe, MD, MPH, Katie Swiezbin, BS, Margaret Chaplin, MD and Gabriela Hoefer
    Cleveland Clinic Journal of Medicine May 2017, 84 (5) 377-384; DOI: https://doi.org/10.3949/ccjm.84a.16091

    Methadone and buprenorphine can reduce craving and opioid use but remain misunderstood and underused.

  • Serotonin syndrome: Preventing, recognizing, and treating it
    Robert Z. Wang, MD, Vishal Vashistha, MD, Sukhdeep Kaur, MBBS and Nathan W. Houchens, MD
    Cleveland Clinic Journal of Medicine November 2016, 83 (11) 810-816; DOI: https://doi.org/10.3949/ccjm.83a.15129

    Serotonin syndrome can be easily overlooked, misdiagnosed, or exacerbated. Early recognition is critical.

Pages